The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis
Open accessAbstract
The neuromodulator adenosine regulates immune activation and neuronal survival through specific G-protein-coupled receptors expressed on macrophages and neurons, including the A1 adenosine receptor (A1AR). Here we show that A1AR null (A1AR-/-) mice developed a severe progressive-relapsing form of experimental allergic encephalomyelitis (EAE) compared with their wild-type (A1AR+/+) littermates. Worsened demyelination, axonal injury, and enhanced activation of microglia/macrophages were observed in A1AR-/-animals. In addition, spinal cords from A1AR-/-mice demonstrated increased proinflammatory gene expression during EAE, whereas anti-inflammatory genes were suppressed compared with A1AR+/+animals. Macrophages from A1AR-/-animals exhibited increased expression of the proinflammatory genes, interleukin-1β, and matrix metalloproteinase-12 on immune activation when matched with A1AR+/+control cells. A1AR-/-macrophage-derived soluble factors caused significant oligodendrocyte cytotoxicity compared with wild-type controls. The A1AR was downregulated in microglia in A1AR+/+mice during EAE accompanied by neuroinflammation, which recapitulated findings in multiple sclerosis (MS) patients. Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener. Thus, modulation of neuroinflammation by the A1AR represents a novel mechanism that provides new therapeutic opportunities for MS and other demyelinating diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Sommer, I., & Schachner, M. (1981) · Developmental Biology · doi:10.1016/0012-1606(81)90477-2 · Cited by 1,134
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872 · cited 1×
“Immunohistochemistry. To detect macrophages/microglia, astrocytes, and neurons, antibodies to ionized calcium binding adaptor molecule 1 (Iba-1) (provided by Dr. Y. Imai; Imai et al., 1996 ), glial fibrillary acidic protein (GFAP) (Dako, Carpinteria, CA), and neuronal nuclei (NeuN) (Chemicon, Temecula, CA) (Iba-1, 1 g…”
MethodMolecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Linden, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.775 · Cited by 685
Matrix metalloproteinases and diseases of the CNS
Wee Yong, V., Forsyth, P. A., Bell, R., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 639
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
Lassmann, H., Brück, W., & Lucchinetti, C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01909-2 · Cited by 627
QUANTIFICATION OF MURINE CYTOKINE mRNAs USING REAL TIME QUANTITATIVE REVERSE TRANSCRIPTASE PCR
Overbergh, L., Valckx, D., Waer, M., & Mathieu, C. (1999) · Cytokine · doi:10.1006/cyto.1998.0426 · Cited by 557
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Adenosine Receptor Subtypes: Characterization and Therapeutic Regulation
Olah, M. E., & Stiles, G. L. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003053 · Cited by 540
Haskó, G., Szabó, C., Németh, Z. H., Kvetan, V, Pastores, S. M., & Vizi, E. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4634 · Cited by 536
Adenosine receptors in the nervous system: pathophysiological implications
Ribeiro, J. A., Sebastião, A. M., & de Mendonça, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00155-7 · Cited by 509
Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12041 · Cited by 456
Targeting leukocyte MMPs and transmigration
Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 426
Self-citationBansal, R., Warrington, A. E., Gard, A. L., Ranscht, B., & Pfeiffer, S. E. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240413 · Cited by 419
Sun, D., Samuelson, L. C., Yang, T., Huang, Y., Paliege, A., Saunders, T., Briggs, J., & Schnermann, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171317998 · Cited by 404
Self-citationLinker, R. A., Mäurer, M., Gaupp, S., Martini, R., Holtmann, B., Giess, R., Rieckmann, P., Lassmann, H., Toyka, K. V., Sendtner, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-620 · Cited by 398
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases
Power, C., Henry, S., Del Bigio, M. R., Larsen, P. H., Corbett, D., Imai, Y., Yong, V. W., & Peeling, J. (2003) · Annals of Neurology · doi:10.1002/ana.10553 · Cited by 363
Self-citationInhibition of TNF-α expression by adenosine: role of A3 adenosine receptors
Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., & Firestein, G. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3435 · Cited by 352
Review: cytokines and the pathogenesis of multiple sclerosis
Navikas, V., & Link, H. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960815)45:4<322::aid-jnr1>3.0.co;2-b · Cited by 328
Zhang, K., McQuibban, G. A., Silva, C., Butler, G. S., Johnston, J. B., Holden, J., Clark-Lewis, I., Overall, C. M., & Power, C. (2003) · Nature Neuroscience · doi:10.1038/nn1127 · Cited by 305
Self-citationDifferential regulatory effects of adenosine on cytokine release by activated human monocytes.
Bouma, M. G., Stad, R. K., van den Wildenberg, F. A. J. M., & Buurman, W. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4159 · Cited by 284
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview
Chandler, S., Miller, K. M., Clements, J. M., Lury, J., Corkill, D., Anthony, D. C. C., Adams, S. E., & Gearing, A. J. H. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00179-8 · Cited by 273
Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes
Oh, L. Y. S., Larsen, P. H., Krekoski, C. A., Edwards, D. R., Donovan, F., Werb, Z., & Yong, V. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08464.1999 · Cited by 267
Self-citationAdenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., von Lubitz, D. K. J. E., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 263
Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity
Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 254
Bauer, J., Huitinga, I., Zhao, W., Lassmann, H., Hickey, W. F., & Dijkstra, C. D. (1995) · Glia · doi:10.1002/glia.440150407 · Cited by 213
Johnston, J. B., Silva, C., Holden, J., Warren, K. G., Clark, A. W., & Power, C. (2001) · Annals of Neurology · doi:10.1002/ana.1131 · Cited by 207
Self-citationGiménez‐Llort, L., Fernández‐Teruel, A., Escorihuela, R. M., Fredholm, B. B., Tobeña, A., Pekny, M., & Johansson, B. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02122.x · Cited by 179
Adenosine enhances IL-10 secretion by human monocytes
Le Moine, O., Stordeur, P., Schandené, L., Marchant, A., de Groote, D., Goldman, M., & Devière, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4408 · Cited by 174
Shi, D., Nikodijević, O., Jacobson, K. A., & Daly, J. W. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00733753 · Cited by 163
Baranzini, S. E., Elfstrom, C., Chang, S.-Y. P., Butunoi, C., Murray, R. S., Higuchi, R., & Oksenberg, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6576 · Cited by 157
Molecular pathogenesis of multiple sclerosis
Bar‐Or, A., de Oliveira, E. M. L., Anderson, D. E., & Hafler, D. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00193-9 · Cited by 121
Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis
Boven, L. A., Vergnolle, N., Henry, S. D., Silva, C., Imai, Y., Holden, J. K., Warren, K. G., Hollenberg, M. D., & Power, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2638 · Cited by 118
Self-citationImmunomodulation in multiple sclerosis: from immunosuppression to neuroprotection
Neuhaus, O., Archelos, J. J., & Hartung, H. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00028-2 · Cited by 111
Johnston, J. B., Silva, C. G., Gonzalez, G. C., Holden, J. K., Warren, K. G., Metz, L. M., & Power, C. (2001) · Annals of Neurology · doi:10.1002/ana.1007 · Cited by 105
Self-citationThe Effect of Long Term Caffeine Treatment on Hypoxic-Ischemic Brain Damage in the Neonate
Bona, E., Ådén, U., Fredholm, B. B., & Hagberg, H. (1995) · Pediatric Research · doi:10.1203/00006450-199509000-00007 · Cited by 101
Stimulation of Interleukin‐6 Secretion and Gene Transcription in Primary Astrocytes by Adenosine
Schwaninger, M., Neher, M., Viegas, E., Schneider, A., & Spranger, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031145.x · Cited by 100
Vos, C. M. P., van Haastert, E. S., Groot, C. J. A. D., van der Valk, P., & de Vries, H. E. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00036-5 · Cited by 97
Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation
Boyle, D. L., Sajjadi, F. G., & Firestein, G. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390608 · Cited by 75
Riches, D. W. H., & Underwood, G. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54298-8 · Cited by 67
Mayne, M. B., Shepel, P. N., Jiang, Y., Geiger, J. D., & Power, C. (1999) · Annals of Neurology · Cited by 67
Self-citationRen, H., & Stiles, G. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10586-5 · Cited by 47
A double-blind pilot study of the effect of Prokarin™ on fatigue in multiple sclerosis
Gillson, G., Richards, T. L., Smith, R. B., & Wright, J. V. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms777oa · Cited by 44
Glucocorticoids Regulate the Expression of Adenosine A1 but not A2A Receptors in Rat Brain
Svenningsson, P., & Fredholm, B. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36484-5 · Cited by 41
Ren, H., & Stiles, G. L. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.309 · Cited by 27
Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview
Miller, S. D., & Shevach, E. M. (1998) · Research in Immunology · doi:10.1016/s0923-2494(99)80002-9 · Cited by 22
Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues
Chou, C., & Vickroy, T. W. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.216 · Cited by 22
Adenosine analogs with covalently attached lipids have enhanced potency at A1‐adenosine receptors
Jacobson, K. A., Zimmet, J. M., Schulick, R. D., Barone, S., Daly, J. W., & Kirk, K. L. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81138-9 · Cited by 16
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Adenosine, an endogenous distress signal, modulates tissue damage and repair
Fredholm, B. B. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402132 · Cited by 686
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Cunha, R. A. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-0649-1 · Cited by 537
Metadata
- Authors
- Tsutsui, S., Schnermann, J., Noorbakhsh, F., Henry, S., Yong, V. W., Winston, B. W., Warren, K., & Power, C.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-02-11
- Volume
- 24
- Issue
- 6
- Pages
- 1521-1529
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2076206556
- Cited by
- 323
- References
- 52
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.